Subacute sclerosing leukoencephalitis
ORPHA:2806DiseaseNot applicableAll ages
Фенотипы (HPO)36
Очень частый (80–99%)3
HP:0000708Atypical behavior
HP:0001268Mental deterioration
HP:0001336Myoclonus
Частый (30–79%)21
HP:0000716Depression
HP:0000726Dementia
HP:0000737Irritability
HP:0000738Hallucinations
HP:0000746Delusion
HP:0001250Seizure
HP:0001254Lethargy
HP:0001288Gait disturbance
HP:0001332Dystonia
HP:0002360Sleep abnormality
HP:0002371Loss of speech
HP:0010856EEG with periodic complexes
HP:0010856EEG with periodic complexes
HP:0012332Abnormal autonomic nervous system physiology
HP:0012424Chorioretinitis
HP:0012444Brain atrophy
HP:0012672Akinetic mutism
HP:0030891Periventricular white matter hyperintensities
HP:0031358Vegetative state
HP:0033044Motor regression
HP:0430088Anti-measles antibody positivity
Периодический (5–29%)12
HP:0000572Visual loss
HP:0000573Retinal hemorrhage
HP:0001085Papilledema
HP:0001251Ataxia
HP:0001257Spasticity
HP:0002071Abnormality of extrapyramidal motor function
HP:0002119Ventriculomegaly
HP:0012229CSF pleocytosis
HP:0012708Reduced brain N-acetyl aspartate level by MRS
HP:0012709Abnormal brain choline/creatine ratio by MRS
HP:0100660Dyskinesia
HP:6000397CSF oligoclonal immunoglobulin G bands
Эпидемиология3
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | <1 / 1 000 000 | — | Europe | Class only |
| Annual incidence | <1 / 1 000 000 | 0.003 | United States | Value and class |
| Annual incidence | 1-9 / 100 000 | 2 | India | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)